Open Trials – Recruiting

TROG Cancer Research radiation therapy trials now recruiting, also known as current or open trials, are those that are fully approved and accepting participants. Our specialised radiation therapy trials are conducted by a team of dedicated professionals. To find out if you are eligible for a trial, please talk to your treating specialist in the first instance.

TROG 17.02 – OUTRUN

Randomised phase II trial of Osimertinib with or without stereotactic radiosurgery for EGFR mutated NSCLC with brain metastases

TROG 18.01 – NINJA

Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

TROG 18.06 – FIG

FET-PET In Glioblastoma

TROG 19.06 – DECREASE

DarolutamidE + Consolidation Radiotherapy in Advanced prostate cancer detected by PSMA

TROG 20.01 – CHEST RT

Chemotherapy Immunotherapy in Extensive Stage Small Cell with Thoracic Radiation therapy

USYD/TROG 17.03 – LARK

Liver Ablative Radiotherapy utilizing Kilovoltage intrafraction monitoring

AGITG/TROG 18.04 – MASTERPLAN

A Randomised Phase II Study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease

ANZ 1601/BIG 16-02/TROG 16.04 – EXPERT

Examining Personalised Radiation Therapy for Low-risk Early Breast Cancer

MASC 03.18/TROG 21.01 – I-MAT

A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

R2810-ONC-1788/TROG 17.11 – CPOST

A randomised, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma
Skip to toolbar